EvoTears

Innovation in Dry Eye & MGD Management

EvoTears® is a unique, preservative free lipid layer replacement eye drop for the management of evaporative dry eye and Meibomian Gland Dysfunction (MGD).  It consists of a single ingredient* that forms a shield on the outer surface of the tear film to protect against evaporation.

 

*Perfluorohexyloctane

Complete Lipid Replacement
Long Lasting
Relief
Preservative and Phosphate Free
6 months use from opening
EvoTears Tear Film Diagram
Click Image To View Full Screen

WHAT IS EVAPORATIVE DRY EYE?

There are two main types of Dry Eye; Aqueous deficient and Evaporative. Which type you have will determine how best to manage your symptoms.

Almost 90% of dry eye patients suffer from Evaporative Dry Eye. This form of Dry Eye occurs when there is an absence of the outer oily lipid layer, leading to evaporation of the aqueous layer. This in turn leads to a reduced tear film, exposing your eye to factors such as wind. This in turn leads to excessive watering, redness, grittiness and overall discomfort to the eye.

What Makes EvoTears® & Perfluorohexyloctane (PFO) Unique

PFO is amphiphilic, meaning it has both hydrophilic and lipophilic properties.

This unique chemistry allows PFO to form a shield on the outer surface of the tearfilm by interacting with both aqueous and lipid layers.

This technology significantly increases the residence time of the product and improves how it spreads over the ocular surface for maximum protection.

100% Pure PFO

PFO acts as a potent evaporation inhibitor.

Since introduction a broad range of clinical and pre-clinical data have confirmed safety, tolerability, efficacy and comfort.

Clinical data on > 2000 subjects with Evaporative Dry Eye Disease supports the safety and efficacy of PFO. Studies ranged from 4 weeks – 1 year and assessed dosages of BID to QID.

Click here for a summary of the clinical research results relating to EvoTears® & Perfluorohexyloctane (PFO).

EvoTears® eases unwanted symptoms associated with evaporative dry eye and MGD such as:

Watery Eyes
Burning Eyes
Red Eyes
Foreign body sensation or grittiness

How EvoTears® Works

RELIEVES symptoms of Evaporative Dry Eye Disease and MGD

REPLACES the outer lipid layer of the tear film creating a protective outer shield

REDUCES evaporation of the tear film by helping to indirectly re-establish the aqueous layer

EvoTears® offers improved tear film stability and symptom relief
for those suffering with Evaporative DED and MGD. In essence, it acts to replace the outer lipid layer, slowing the rate of evaporation of the aqueous layer.

 

In this video, watch how EvoTears® reduces the evaporation of a simulated tear by more than half.

Small Drops, Big benefits

Water, preservative & phosphate free

Low surface tension

Convenient 3ml bottle – easy to carry and use

>280 drops - 4 drops a day for 70 day

6 months use after opening

No pH/Osmolarity therefore no stinging or burning in the eye

Rapid spread across the ocular surface

Minimal visual impairment

Long lasting relief

Minimises spill over

Water, preservative & phosphate free

No pH/Osmolarity therefore no stinging or burning in the eye

Low surface tension

Rapid spread across the ocular surface

Long lasting relief

Minimal visual impairment

Minimises spill over

Convenient 3ml bottle – easy to carry and use

>280 drops - 4 drops a day for 70 day

6 months use after opening

Request your free sample today

Fill out the form below and a member of our team will contact you
Registration is open!Reserve your spot for the next Dry Eye Well-being Seminar

The Benefits of Preservative Free Drops
  • Benzalkonium chloride (BAK) is the most frequently used preservative in preserved eye drops. BAK can induce corneal and conjunctival epithelial cell apoptosis, damage corneal nerves, delay wound healing, interfere with tear film stability and cause loss of goblet cells.3
  • The negative symptoms experienced through the use of BAK-preserved drops may impact adherence to the prescribed treatment or management regime.4
  • Preservative-free tear replacement is preferred in cases of frequent and chronic application.5
  • Patients with Dry Eye Disease (DED), especially those with severe DED who require dosing over 4 times daily with lubricants or who use ocular lubricants in conjunction with other chronic topical therapies such as glaucoma medications, should avoid the use of ocular lubricants containing preservative.3
HYLO-Tear and HYLO-Forte Price Comparison
Product HYLO Tear HYLO Forte Evolve HA Hyabak Thealoz Duo
Drug Tariff price1 £8.50 £9.50 £5.99 £8.99 £7.99
Average duration of scripts (days) 30.31 30.65 19.78 27.07 25.55
Annual cost to ICS per patient £102.36 £111.85 £110.53 £128.43 £107.73

 

*Analysed data for preservative free (PF) ocular lubricants from Cegedim’s THIN database, Jan 2020-Dec 2020 (Representative of 400+ GP practices & 3.2M patient population)